CAS No. : 1609452-30-3
|Size||Stock||Price||Quantity||Add to Cart||Quotation Online|
|Cat. No. :||CS-0040595|
|CAS No. :||1609452-30-3|
|M. Wt. :|
SEL120-34A HCl is a potent, selective, orally available, ATP-competitive CDK8 inhibitor, with IC50s of 4.4 nM and 10.4 nM for CDK8/CycC and CDK19/CycC, respectively, with antitumor activity. IC50 & Target: IC50: 4.4 nM (CDK8/CycC), 10.4 nM (CDK19/CycC) In Vitro: SEL120-34A HCl is a selective, ATP-competitive CDK8 inhibitor, with IC50 of 4.4 nM and 10.4 nM for CDK8/CycC and CDK19/CycC, respectively. SEL120-34A HCl shows no obvious inhibition on CDK1, 2, 4, 6, 5, 7, and only weakly suppresses CDK9 (IC50, 1070 nM). SEL120-34A HCl is active against a panel of AML cell lines (GI50<1 μM), such as SKNO-1, KG-1, HEL-60, MOLM-16, MV-4-11, OciAML-2, MOLM-6 and OciAML-3 cells, consistent with the effective inhibition range of STAT1 S727 and STAT5 S726. In Vivo: SEL120-34A (30, 60 mg/kg, p.o.) inhibits the growth of tumor in mice bearing MV4-11 cancer cells, and also arrests the growth of KG-1-derived tumors at 30 mg/kg via oral administration.
Rzymski T, et al. SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains. Oncotarget. 2017 May 16;8(20):33779-33795.
|Tags:SEL120-34A HCl supplier,SEL120-34A HCl purchase,SEL120-34A HCl manufacturer,SEL120-34A HCl sigma,SEL120-34A HCl distributor,cost,SEL120-34A HCl buy,SEL120-34A HCl for sale|